Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Take proper precautions and seek timely treatment!
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Subscribe To Our Newsletter & Stay Updated